Humana Says Acthar's Meteoric Price Hike Cost It $700M
By Nadia Dreid · August 9, 2019, 10:09 PM EDT
Mallinckrodt ran "one of the most outrageous price-gouging schemes in the history of American medicine" on its hormone gel used primarily to treat an infant seizure syndrome, according to a new...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login